genedrive plc (AIM:GDR)
London · Delayed Price · Currency is GBP · Price in GBX 1.000
+0.025 (2.56%)
At close: Dec 5, 2025
genedrive Market Cap
genedrive has a market cap or net worth of 10.3 million as of December 5, 2025. Its market cap has decreased by -21.01% in one year.
Market Cap
10.30M
Enterprise Value
9.11M
Revenue
954.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since April 10, 2007, genedrive's market cap has decreased from 11.67M to 10.30M, a decrease of -11.78%. That is a compound annual growth rate of -0.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 10.04M | -24.56% |
| Dec 31, 2024 | 13.31M | 33.76% |
| Dec 29, 2023 | 9.95M | -2.27% |
| Dec 30, 2022 | 10.18M | -74.34% |
| Dec 31, 2021 | 39.68M | 29.49% |
| Dec 31, 2020 | 30.64M | 290.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| GSK plc | 73.29B |
| Haleon | 32.16B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.46B |
| Hikma Pharmaceuticals | 3.52B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.77B |